Status:

RECRUITING

Increased Early Pain Relief by Adding Vertebroplasty to SBRT

Lead Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Conditions:

Spine Metastases

Radiation Therapy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of treating metastases is to preserve stability and neurological function while reducing pain. The actual standard of care is stereotaxic body radiation therapy (SBRT) alone in non-surgical p...

Eligibility Criteria

Inclusion

  • Histological evidence of cancer.
  • Spinal and vertebral bone metastases (T5 to L5) documented by imaging.
  • Pain related to metastases ≥ 4 on a numerical scale 0-10.
  • Karnofsky performance index \> 60 (ecog 0-2)
  • Candidate for SBRT
  • Less than 3 consecutive levels reached.
  • Ability to complete follow-up questionnaires regarding pain, analgesics, and quality of life assessment.
  • Potentially unstable lesions according to the spinal instability neoplastic score (SINS) scale (\> or = 7)

Exclusion

  • Pregnancy or breastfeeding.
  • Contraindications to MRI.
  • Histology: myeloma, lymphoma or plasmacytoma.
  • Radiotherapy prior to the level to be treated.
  • Previous surgery at the site to be treated.
  • Surgical indication:
  • spinal instability neoplastic score (SINS) \> 13 or according to tumor board consensus.
  • Bilsky score \> or = 2 Severe or progressive neurological signs (motor, incontinence).
  • Lesion too large for safe vertebroplasty.
  • High thoracic location not allowing safe visibility in fluoroscopy to perform vertebroplasty (T4 and above).
  • Non-reversible coagulation disorders.
  • Uncontrolled local or systemic infection.
  • Estimated survival of less than 6 months.
  • Inability or refusal to undergo SBRT treatment or vertebroplasty

Key Trial Info

Start Date :

November 22 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05317026

Start Date

November 22 2023

End Date

December 31 2027

Last Update

August 7 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

CHUM

Montreal, Quebec, Canada, H2X0C1

2

Véronique Freire

Montreal, Quebec, Canada